GEO · The GEO Group, Inc.

The thesis

The company confirmed on 19 October 2026 that it redeemed all $650 million of 8.625% senior secured notes due 2029 on 15 October 2026, using proceeds from the $950 million Adelanto sale. The election and the first report after the sale settle whether the balance-sheet gains carry into earnings.

The shares closed at $28.27 on 27 October 2026, 13.7% below the $32.77 52-week high in the adjusted daily closes. They closed at $30.81 on 14 October 2026, the date of the previous note. The three-month price change is -7.8%, and the 14-day relative strength index, a momentum gauge, is 37.0.

The narrative is maturing: the Big Horn and Rivers contracts and the Adelanto sale are well known, and the newest company fact, the note redemption, is a debt-reduction step already signalled on 5 October 2026. Attention has moved to election risk and to critical coverage of detention operations. The medium rating stands. The fall in the price changes how much good news is priced in, not the company filings behind the case.

Bullish and bearish views on The GEO Group, Inc.

The bull case on The GEO Group, Inc. (GEO), in brief: The sale funded a debt redemption. The bear case: The price has not confirmed the news.

Bull case

• The sale funded a debt redemption. GEO redeemed all $650 million of 8.625% senior secured notes due 2029 at $1,043.13 per $1,000 of principal, about $678 million plus accrued interest. The indenture was discharged on 15 October 2026 (company release, 19 October 2026).
• The revolver is undrawn and extended. The $550 million revolving credit facility now matures on 14 July 2031, and GEO reported no borrowings under it as of 19 October 2026 (company release, 19 October 2026).
• Buyback room is large. The board raised the repurchase authorization by $750 million to $1.25 billion through 31 December 2029 (GEO Form 8-K, 5 October 2026). Under the amended credit agreement, repurchases are unrestricted while pro forma leverage is at or below 2.25 times (company release, 19 October 2026).
• Operating revenue stays in place. GEO continues to run the three Adelanto facilities under its ICE contract, which runs through 19 December 2034 including a five-year option (GEO Form 8-K, 5 October 2026).
• Guidance was raised in August. Second-quarter revenue was $732.1 million, up 15% year over year. Fiscal 2026 GAAP (generally accepted accounting principles) earnings per share guidance was raised to $1.27–$1.32 on 6 August 2026 (GEO Form 8-K).
• Analyst targets sit far above the price. MarketBeat reported a consensus target of $40.00 on 29 September 2026. At the $28.27 close on 27 October 2026, that target is well above the shares.

Bear case

• The price has not confirmed the news. The shares closed at $28.27 on 27 October 2026, against $30.81 on 14 October 2026, after the sale, buyback increase and redemption were all public.
• Election risk is unresolved. GEO depends on federal detention contracts, and the 3 November 2026 election shapes immigration-enforcement funding. The continuing resolution expires on 11 December 2026.
• Public scrutiny is rising. Al Jazeera released a documentary on operations at a GEO facility on 23 October 2026. Bloomberg Law reported on 19 October 2026 that ICE private prison contracts face a difficult environmental fight.
• Earnings effect of the sale is unstated. The 5 October 2026 release gave no guidance on facility income after the sale. GEO guided third-quarter GAAP EPS of $0.35–$0.37 on revenue of $755–$805 million (GEO Form 8-K, 6 August 2026).
• Insiders sold into strength. Director-level and executive Form 4 filings show Ronald A. Brack sold 7,000 shares at $32.00 on 21 August 2026, and VP Matthew Albence sold 11,797 shares at $31.45 on 11 September 2026 (MarketBeat, SEC Form 4).

Price setup

The adjusted daily close was $28.27 on 27 October 2026. The 52-week high is $32.77, and the shares sit 13.7% below it. The 3-month change is -7.8%, and the relative strength index of 37.0 is weak but not at an oversold reading of 30 or below.

The previous note placed its invalidation level at a weekly close of $28. The last close is $0.27 above that level. A decline through it would take the shares below the range of the past several weeks.

Crowding evidence is limited to two items: the third-quarter report is nine days away, and executives sold shares at $31 to $32 in August and September. No wide gap above a rising moving average exists, because the shares are below their recent highs.

Catalysts, next 30 days

• It tests the $0.35–$0.37 GAAP EPS guidance and updates Big Horn and Rivers activation.
• 11 December 2026 (outside 30 days): continuing resolution expires. It frames the federal funding path.

Elapsed catalysts

• 3 November 2026: US midterm elections. The outcome shapes the federal funding environment for detention. (passed 3d ago)
• Unscheduled: further facility sales to ICE. Management said on 5 October 2026 that talks continue, with no definitive agreement or timeline. (passed 32d ago)

What would change the view

The case breaks if the third-quarter report cuts fiscal 2026 GAAP EPS guidance below $1.27, discloses an activation delay past 31 December 2026 at Big Horn or Rivers, or shows a cancellation of either contract. It also breaks if post-election legislation or appropriations language reduces ICE detention funding. Little repurchase activity after the sale would weaken the buyback leg of the case. A daily close below $28 would put the shares below the recent trading range.

What it trades with

GEO trades on federal immigration-enforcement policy and election outcomes, and moves with CoreCivic more closely than with the S&P 500. Revenue depends on US federal agencies and state corrections departments, so the main risks are political and legal rather than tied to the economic cycle. Facility awards and property sales arrive unscheduled, by press release and 8-K filing.